TAK · NYSE · Drug Manufacturers - Specialty & Generic

Takeda (ADR)

Develops prescription medicines across gastrointestinal disease, rare disease, plasma therapies, oncology, neuroscience, and vaccines.

$18.49
After-hours close+0.46 (+2.53%)
At close$18.03(0.00%)
DateEstimateReportedSurprise
Oct 2026$0.14
Jul 2026$0.17$0.23+33.2%
May 2026$0.21$0.28+33.3%
Jan 2026$0.55$0.48−12.7%
Oct 2025$0.44$0.440.0%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Jul 2025
Jun 2025
Jan 2025
Oct 2024
Jul 2024
May 2024
Feb 2024
Oct 2023
Jul 2023
May 2023
Feb 2023
May 2022
Feb 2022
May 2021
Oct 2020
Jul 2020
May 2020
Feb 2020
Oct 2019
Jul 2019
May 2019
Feb 2019
Oct 2018
Jul 2018
May 2018
Dec 2017
Sep 2017
Jun 2017
Mar 2017
Dec 2016
Sep 2016
Jun 2016
Mar 2016
Dec 2015
Sep 2015
Jun 2015
Mar 2015
Dec 2014
Sep 2014
Jun 2014
Mar 2014
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Oct 29, 2026$0.14$7.23B
Jul 30, 2026$0.17$0.23+33.2%$7.13B$7.66B+7.4%
May 13, 2026$0.21$0.28+33.3%$7.14B$6.92B−3.0%
Jan 29, 2026$0.55$0.48−12.7%$7.54B$7.73B+2.5%
Oct 30, 2025$0.44$0.440.0%$7.48B$7.42B−0.9%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Jul 30, 2025
Jun 25, 2025
Jan 30, 2025
Oct 31, 2024
Jul 31, 2024
May 9, 2024
Feb 1, 2024
Oct 26, 2023
Jul 27, 2023
May 11, 2023
Feb 2, 2023
May 11, 2022
Feb 3, 2022
May 11, 2021
Oct 29, 2020
Jul 31, 2020
May 13, 2020
Feb 4, 2020
Oct 31, 2019
Jul 31, 2019
May 14, 2019
Feb 1, 2019
Oct 31, 2018
Jul 31, 2018
May 14, 2018
Dec 31, 2017
Sep 30, 2017
Jun 30, 2017
Mar 31, 2017
Dec 31, 2016
Sep 30, 2016
Jun 30, 2016
Mar 31, 2016
Dec 31, 2015
Sep 30, 2015
Jun 30, 2015
Mar 31, 2015
Dec 31, 2014
Sep 30, 2014
Jun 30, 2014
Mar 31, 2014